Physician profile
Derrick Allen Strunk
NPI 1447664420
$1,538.13
in general payments reported to CMS, 2019-2025
10 companies · $223 in 2025
The $223 reported for 2025 was more than what 83% of Hospice and Palliative Medicine (Family Medicine) providers received nationally (typical 2025 total: $78.57).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.15 · 2022: $244 · 2023: $441 · 2024: $616 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,279.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $460.17 | 2022-2025 | Austedo Xr, Uzedy, Austedo |
| Lundbeck LLC | $328.70 | 2022-2024 | Rexulti, Abilify Maintena |
| Otsuka America Pharmaceutical, INC. | $271.12 | 2022-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Alkermes, INC. | $259.84 | 2022-2025 | Aristada, Lybalvi, Vivitrol |
| Abbvie INC. | $57.58 | 2023-2025 | Vraylar |
| Axsome Therapeutics, INC. | $55.46 | 2022-2025 | Auvelity, Sunosi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $54.83 | 2023-2025 | Caplyta |
| Luye Pharma (USA) Ltd. | $23.08 | 2025 | Erzofri Extended-Release |
| Allergan, INC. | $14.15 | 2020 | |
| Bioxcel Therapeutics, INC. | $13.20 | 2023 | Igalmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derrick Strunk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.